Fragment-Based Drug Design of Novel Pyranopyridones as Cell Active and Orally Bioavailable Tankyrase Inhibitors

od de Vicente, Javier, Tivitmahaisoon, Parcharee, Berry, Pamela, Bolin, David R., Carvajal, Daisy, He, Wei, Huang, Kuo-Sen, Janson, Cheryl, Liang, Lena, Lukacs, Christine, Petersen, Ann, Qian, Hong, Yi, Lin, Zhuang, Yong, Hermann, Johannes C.
Izdano u ACS Med Chem Lett (2015)

Inhibition of IRF5 cellular activity with cell-penetrating peptides that target homodimerization

od Banga, Jaspreet, Srinivasan, Dinesh, Sun, Chia-Chi, Thompson, Cherrie D., Milletti, Francesca, Huang, Kuo-Sen, Hamilton, Shannon, Song, Su, Hoffman, Ann F., Qin, Yajuan Gu, Matta, Bharati, LaPan, Margaret, Guo, Qin, Lu, Gang, Li, Dan, Qian, Hong, Bolin, David R., Liang, Lena, Wartchow, Charles, Qiu, Jin, Downing, Michelle, Narula, Satwant, Fotouhi, Nader, DeMartino, Julie A., Tan, Seng-Lai, Chen, Gang, Barnes, Betsy J.
Izdano u Sci Adv (2020)